• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ETV6-NTRK3 易位相关的低级别黏液性支气管腺癌:一种新型的支气管涎腺型非小细胞肺癌亚型。

ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma: A novel bronchial salivary gland-type non-small cell lung cancer subtype.

机构信息

Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

出版信息

Lung Cancer. 2021 Jun;156:72-75. doi: 10.1016/j.lungcan.2021.04.015. Epub 2021 Apr 16.

DOI:10.1016/j.lungcan.2021.04.015
PMID:33895680
Abstract

INTRODUCTION

NTRK fusion genes have been found in several solid tumors, among which NSCLC and sarcoma. Novel NTRK translocation-related tumors are still being discovered.

METHODS

We report a 49-year-old patient with a mass in the left lower lung lobe that was resected. This specimen was analyzed and sequenced using targeted DNA next generation sequencing (NGS) and anchored-multiplex-PCR (AMP) targeted RNA NGS.

RESULTS

On pathological evaluation, a peribronchial mucinous neoplasm with a unique morphology was found. RNA NGS analysis showed anETV6-NTRK3 translocation in a low-grade mucinous bronchial adenocarcinoma.

CONCLUSIONS

This entity represents a novel subtype of non-small cell lung cancer, which we would like to term 'ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma'.

摘要

简介

NTRK 融合基因已在多种实体肿瘤中被发现,包括 NSCLC 和肉瘤。新的 NTRK 易位相关肿瘤仍在不断被发现。

方法

我们报告了一例 49 岁患者,其左肺下叶有一个肿块,已行切除术。该标本通过靶向 DNA 下一代测序(NGS)和锚定多重-PCR(AMP)靶向 RNA NGS 进行分析和测序。

结果

在病理评估中,发现一种具有独特形态的支气管周围黏液性肿瘤。RNA NGS 分析显示在低度黏液性支气管腺癌中存在 ETV6-NTRK3 易位。

结论

该实体代表一种新型非小细胞肺癌亚型,我们将其命名为“ETV6-NTRK3 易位相关低度黏液性支气管腺癌”。

相似文献

1
ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma: A novel bronchial salivary gland-type non-small cell lung cancer subtype.ETV6-NTRK3 易位相关的低级别黏液性支气管腺癌:一种新型的支气管涎腺型非小细胞肺癌亚型。
Lung Cancer. 2021 Jun;156:72-75. doi: 10.1016/j.lungcan.2021.04.015. Epub 2021 Apr 16.
2
Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.扩展唾液腺癌的分子谱,发现一种新型的 VIM-RET 融合。
Am J Surg Pathol. 2020 Oct;44(10):1295-1307. doi: 10.1097/PAS.0000000000001535.
3
Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report.涎腺分泌型癌中存在一种不常见但具有高度显著意义的 ETV6-NTRK3 重排的 FISH 信号模式的特征:病例报告。
Diagn Pathol. 2021 Aug 9;16(1):73. doi: 10.1186/s13000-021-01133-z.
4
Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.唾液腺癌中的新型基因融合:扩大 ETV6 家族。
Hum Pathol. 2019 Jan;83:50-58. doi: 10.1016/j.humpath.2018.08.011. Epub 2018 Aug 18.
5
Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.涎腺乳腺样分泌性癌:25例ETV6基因重排肿瘤的分子分析,标准逆转录聚合酶链反应未检测到经典ETV6-NTRK3融合转录本:4例携带ETV6-X基因融合病例报告
Am J Surg Pathol. 2016 Jan;40(1):3-13. doi: 10.1097/PAS.0000000000000537.
6
Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.伴有 ETV6::NTRK3 融合的低级别气管腺癌:具有独特形态,类似于鼻腔鼻窦低级别非肠型腺癌的某些亚型。
Virchows Arch. 2022 Nov;481(5):793-797. doi: 10.1007/s00428-022-03353-0. Epub 2022 Jun 7.
7
Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.31 例 ETV6-NTRK3 融合基因阳性(乳腺型)涎腺分泌型癌患者的临床病理特征和预后分析。
Oral Oncol. 2018 Jul;82:29-33. doi: 10.1016/j.oraloncology.2018.04.022. Epub 2018 May 11.
8
Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.乳腺型分泌性涎腺癌,含有 ETV6-NTRK3 融合基因:一种迄今尚未描述的涎腺肿瘤实体。
Am J Surg Pathol. 2010 May;34(5):599-608. doi: 10.1097/PAS.0b013e3181d9efcc.
9
Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.Pan-Trk 免疫组化是诊断唾液腺癌和检测 ETV6-NTRK3 融合的一种敏感且特异的辅助工具。
Histopathology. 2020 Feb;76(3):375-382. doi: 10.1111/his.13981. Epub 2019 Dec 11.
10
High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.伴有 ETV6::NTRK3 融合的高级别非肠道型鼻窦腺癌,通过免疫表型和形态学与分泌性癌不同。
Virchows Arch. 2023 Aug;483(2):187-195. doi: 10.1007/s00428-023-03587-6. Epub 2023 Jul 6.

引用本文的文献

1
Bronchial salivary gland-type mucinous adenocarcinoma harboring a GNAS mutation: a novel lung cancer entity? A case report.携带GNAS突变的支气管涎腺型黏液腺癌:一种新型肺癌实体?病例报告
Virchows Arch. 2024 Nov 5. doi: 10.1007/s00428-024-03956-9.
2
ETV6::NTRK3-associated papillary adenocarcinoma: let us play it by ear.ETV6::NTRK3相关的乳头状腺癌:我们得随机应变。
Virchows Arch. 2024 Dec;485(6):1161-1165. doi: 10.1007/s00428-024-03735-6. Epub 2024 Jan 11.
3
Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected Patients.
非小细胞肺癌中的基因融合:1068例未经筛选患者的真实世界筛查数据
Cancers (Basel). 2023 May 29;15(11):2966. doi: 10.3390/cancers15112966.
4
A unique case of inflammatory myofibroblastic tumor of the liver manifesting with biloma: A case report.一例以胆汁瘤为表现的肝脏炎性肌纤维母细胞瘤罕见病例:病例报告
Oncol Lett. 2022 May 26;24(1):227. doi: 10.3892/ol.2022.13348. eCollection 2022 Jul.
5
Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.伴有 ETV6::NTRK3 融合的低级别气管腺癌:具有独特形态,类似于鼻腔鼻窦低级别非肠型腺癌的某些亚型。
Virchows Arch. 2022 Nov;481(5):793-797. doi: 10.1007/s00428-022-03353-0. Epub 2022 Jun 7.